← All insights▼
▼
Sponsor–Industry Alignment· Sponsor ↔ sector
Angie Craig (D) is primary sponsor of Pharmaceuticals & Biotech bill hr6833-117; Pharmaceuticals & Biotech is a top donor industry (3%)
The bill hr6833-117 would cap insulin cost-sharing at $35 monthly for private insurance and Medicare beneficiaries, directly affecting the Pharmaceuticals & Biotech industry. Representative Angie Craig (D-MN) introduced the bill. Pharmaceuticals & Biotech represents 2.8% of Craig's identifiable donor base ($0.47M), ranking 48th among 252 donor industries within her party.
PHR
Pharmaceuticals & Biotech
top donor sector
gave $467K
3% of their funding
▶
Angie Craig
D-MN · House
sponsored
industry: pharma
▶
BILL
HR6833-117
their bill
3%
of their classified donations are from this sector
$467K
from Pharmaceuticals & Biotech
#48
most-funded by this sector in their party (of 252)
FOLLOW THE TRAIL
◈ Ask the Analyst about Angie Craig →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 26, 2026 · internal signal score 47/100.